What interventions are recommended for a patient who develops a runny nose while using continuous positive airway pressure (CPAP) therapy?

Management of CPAP-Induced Runny Nose

Add heated humidification to the CPAP device immediately, as this is the primary evidence-based intervention that significantly reduces nasal discharge and other nasal symptoms in CPAP users. 1

Primary Intervention: Heated Humidification

The 2019 American Academy of Sleep Medicine clinical practice guideline explicitly recommends that clinicians should generally use heated humidification with PAP devices to reduce side effects that occur while treating adults with OSA 1. Meta-analyses demonstrated clinically significant reduction in multiple nasal symptoms including:

• Nasal discharge (runny nose)
• Dry mouth/throat
• Nasal congestion
• Dry nose
• Bleeding nose
• Sinus pain or headache

The guideline acknowledges that while heated humidification doesn't improve CPAP adherence, sleepiness, or quality of life in meta-analyses, it effectively addresses the specific nasal symptoms that patients find troublesome 1. Research confirms that heated humidification reduces nasal resistance and mucosal inflammation, with the inflammatory nature of CPAP-induced nasal obstruction being attenuated by this intervention 2.

Important Caveat About "Rain Out"

Be aware that heated humidification can cause condensation of water into the PAP circuit, face, and nose ("rain out"), which may deter some patients 1. Using a heated hose can minimize this problem. The increased costs (distilled water, heated hoses) and maintenance requirements are trade-offs worth discussing with patients.

Secondary Intervention: Intranasal Corticosteroids

If heated humidification alone is insufficient after 30 days, add intranasal corticosteroids (fluticasone furoate 55 μg daily) 3. A 2021 randomized controlled trial demonstrated that intranasal steroids:

• Significantly decreased rhinorrhea and congestion symptoms after 90 days (P < 0.001)
• Increased CPAP compliance compared to controls
• Required 90 days of treatment to show full benefit (no difference at 30 days)

The mechanism involves reducing the inflammatory response that CPAP induces in the nasal mucosa 2.

Tertiary Option: Combined Therapy for Refractory Cases

For patients with concurrent allergic rhinitis who remain intolerant despite the above measures, consider adding once-daily intranasal oxymetazoline to the intranasal steroid regimen 4. A 2025 case report showed this combination improved CPAP tolerance in a patient who failed fluticasone alone.

Critical safety note: Use oxymetazoline once daily (not twice daily) in combination with the steroid to avoid rhinitis medicamentosa. This approach has been shown effective for 4 weeks without rebound congestion when used once daily with concurrent steroid therapy 4.

Mask Interface Consideration

While addressing runny nose, also verify the patient is using a nasal or intranasal mask interface rather than an oronasal (full-face) mask 1. The guideline demonstrates fewer side effects with nasal compared to oronasal interfaces, which may compound nasal symptoms.

Algorithmic Approach

1. First-line (immediate): Add heated humidification with heated hose
2. If inadequate after 30 days: Add intranasal fluticasone furoate 55 μg daily
3. Reassess at 90 days: Full benefit of intranasal steroids requires 3 months
4. If still refractory: Consider adding once-daily oxymetazoline to steroid (monitor for rhinitis medicamentosa)
5. Throughout: Ensure nasal/intranasal mask interface is being used

This stepwise approach addresses the inflammatory pathophysiology of CPAP-induced nasal symptoms while maximizing adherence to therapy 2, 5.